Breast cancer is the number one killer threatening women's health worldwide, and the number of new breast cancer patients is increasing year by year.In order to provide more accurate and comprehensive diagnosis and treatment services for breast cancer patients, after careful planning, the Breast Cancer Clinical Prevention and Treatment Center of St. Stanford Modern Cancer Hospital Guangzhou was officially reopened.
At 8:30 a.m. on June 28, the re-opening ceremony of the Breast Cancer Clinical Prevention and Control Center (Breast Cancer Ward) of our hospital was held on the 8th floor. President Wang Huaizhong, Director Yang Jinna of the hospital Office, Director Dai Wenyan of the Breast Cancer Clinical Prevention and Control Center, Assistant Director Liu Yansheng of the International Affairs Department, Director He Fengyu of the Sensory Control Department and other hospital leaders and medical staff of the 8th floor jointly attended the re-opening ceremony.
Hospital leaders and breast cancer Clinical Prevention and Control center medical staff
As the leader of the Breast Cancer Clinical Prevention and Control Center, Director Dai Wenyan first delivered a speech. She introduced the relevant data on the incidence of breast cancer: according to statistics, breast cancer has become the world's largest new cancer in 2020, with 2.26 million new patients diagnosed with breast cancer every year. Despite the highest incidence, the mortality rate of breast cancer is not high, most patients with stage 1 to 3 can be cured, 70% of patients with stage 4 breast cancer survive 2 to 5 years, and 30% of cases survive more than 5 years.
President Wang Huaizhong (left) and Director of Breast Cancer Clinical Prevention Center Dai Wenyan of St. Stanford Modern Cancer Hospital Guangzhou
In response to the reopened, she said with joy: "The restart of the breast department is an important milestone in the development of our hospital, aiming to strengthen the discipline construction and improve the quality of breast cancer diagnosis and treatment, and provide more accurate, comprehensive and safe one-stop diagnosis and treatment services for the majority of breast cancer patients." I hope to lead all the medical staff to work together to build the breast department into an efficient and high-quality excellent department."
Subsequently, Mr. Wang Huaizhong, president of St. Stamford Modern Cancer Hospital Guangzhou, delivered a speech in which he reviewed the previous brilliant achievements of the breast specialty. It is reported that the breast department of our hospital was established in 2016, after 4 years of cultivation and creation, it has formed a set of standardized treatment mode and highlighted the characteristics of our hospital which have brought a solid effect to many breast cancer patients, it has won wide praise and warm response from all walks of life. Under the leadership of Director Dai Wenyan, the breast specialist team has won several Guangzhou municipal scientific research achievement awards, published a number of professional papers in top domestic journals, and the treatment technology and program of the department has been in line with the domestic and international advanced level, and has accumulated rich experience in clinical practice.
He said that the breast specialty was closed due to the epidemic, and now it is restarted, and the hospital is to meet the diagnosis and treatment needs of the majority of breast cancer patients, providing them with more accurate and comprehensive diagnosis and treatment services throughout the whole course of the disease. At the same time, the hospital will vigorously support the development of the breast specialty in terms of talent cultivation, equipment and medical technology.
Finally, the awarding ceremony was held, and President Wang Huaizhong awarded the Breast cancer Clinical Prevention and treatment Center. In the bursts of applause and congratulations from the participating guests, the Breast Cancer Clinical prevention and treatment Center of our hospital announced the official restart.
Director Dai Wenyan led the breast cancer Clinical Prevention Center team photo
In the past two years, our hospital has continuously introduced the world's cutting-edge minimally invasive treatment technology, such as the introduction of Comboknife cold and heat ablation, interventional drug-loaded microsphere therapy, etc., combined with 18 advanced minimally invasive technologies such as nanomatknives, iodine particle implantation, microwave ablation, etc., to keep pace with The Times in terms of technical support. In terms of talent, the breast department is managed by Director Dai Wenyan with 20 years of clinical experience, she is currently serving as the director of the Youth Council of the Chinese Anti-Cancer Association and the deputy director of the breast branch of the Guangdong Medical Industry Association. She is especially good at minimally invasive treatment of middle and advanced breast cancer, and has gained many patients' banner and praise because of her exquisite medical skills and good curative effect.
With the restart of the breast specialty, Modern Cancer Hospital Guangzhou will conduct research on subdivision of diseases, upgrade from the previous broad tumor treatment to the precision treatment of breast cancer, integrate the existing technology and talent of the hospital, and promote the development of breast cancer treatment towards a more specialized and refined direction.
In today's rapidly changing medical science, this is a new starting point, a new journey, our hospital will open a new chapter in the precision treatment of breast cancer, and strive to make continuous progress in the treatment of breast cancer, to bring more breast cancer patients smile and Gospel!
*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.